NR4A1 and neoplasm: The clinical presentation of patients with MBC is larger tumor size, higher grade and stage, more hormone receptor-negative tumors with less frequent involvement of regional nodes, and a higher likelihood of distant metastasis in comparison to classical breast invasive carcinoma [5].